Prostate cancer provides another compelling example of glycosylation-driven malignancy, with overexpression of ST6GAL1 catalyzing α2,6 sialylation of N-glycans, which promotes tumor growth, invasion, and resistance to apoptosis [346]. The gene discussed is ST6GAL1; the disease is neoplasm.